ALLISON STEVENS: Open Payments
NPI 1265986319 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 56 payments from 16 companies in 2025. Trend: 2023 $282 · 2024 $691 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $181 |
| Novartis Pharmaceuticals Corporation | 17 | $169 |
| SCPHARMACEUTICALS INC. | 6 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $108 |
| Merck Sharp & Dohme LLC | 6 | $104 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $72 |
| Novo Nordisk Inc | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 3 | $50 |
| Imperative Care, Inc | 2 | $46 |
| Impulse Dynamics (USA) Inc. | 2 | $42 |
Products named: SAPIEN 3 Ultra RESILIA, LEQVIO, FUROSCIX, JARDIANCE, VERQUVO, LifeVest, SYMPHONY CATHETER, Optimizer.
Industry payments across NJ — which companies pay providers there.
